Prof. Stephen Locarnini
Honorary
Microbiology and Immunology
387 Scholarly works
6 Projects
HIGHLIGHTS
2021
Journal article
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase
DOI: 10.1002/hep.315162020
Journal article
Real-world application of the Xpert (R) HBV viral load assay on serum and dried blood spots
DOI: 10.1002/jmv.266622018
Research Grant
NOVEL EARLY DETECTION STRATEGY FOR LIVER CANCER USING HEPATITIS B SPLICE VARIANTS TO EXPEDIATE DIAGNOSIS AND IMPROVE TREATMENT OUTCOME
2017
Research Grant
CHARACTERISATION OF ANTI-HBS RESPONSES IN PATIENTS UNDERGOING FUNCTIONAL HEPATITIS B CURE: IMPLICATION FOR FUTURE THERAPIES
2016
Research Grant
LONG TERM PERSISTENCE OF HIV IN THE LIVER AND THE CLINICAL IMPACT ON HIV-HBV CO-INFECTION
2004
Journal article
Hepatitis B virus: pathogenesis, viral intermediates, and viral replication
DOI: 10.1016/j.cld.2004.02.0092003
Journal article
New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B
DOI: 10.1053/jhep.2003.50389
RECENT SCHOLARLY WORKS
2020
Journal article
Hepatitis B related dilemmas in the renal unit
DOI: 10.1111/nep.138152020
Conference Proceedings
HBV-STOP study: Large hepatitis B virus flares off nucleot(s)ide analog therapy cause large innate immune response
2020
Conference Proceedings
FUNCTIONAL CURE OF CHRONIC HEPATITIS B IS ASSOCIATED WITH CO-OCCURRENCE OF HBsAg/ANTI-HBS IMMUNE COMPLEXES WITH ALT FLARES, AND SEROCONVERSION TO NEUTRALISING ANTI-HBS
2020
Conference Proceedings
A prospective study of nucleot(s)ide analog discontinuation in non-cirrhotic patients with HBeAg-negative chronic hepatitis B: Interim analysis identifies different viral kinetics after stopping tenofovir versus entecavir
2020
Journal article
Hepatitis B and D in the Pacific Islands of Kiribati
DOI: 10.1016/j.jcv.2020.1045272020
Journal article
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis B
DOI: 10.1111/jvh.133182020
Journal article
The evolution and clinical impact of hepatitis B virus genome diversity
DOI: 10.1038/s41575-020-0296-62020
Journal article
Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity
DOI: 10.1016/j.vaccine.2020.03.007